Our Research

Our Research

  • Our research is aimed at developing safe, efficient, and clinically viable biomaterials and nanoparticulate delivery systems for targeting, controlled release and depot effect of therapeutic agents/vaccine to their site of action.
  • Delivery of therapeutic agents for the treatment of lung and systemic diseases via dry powder inhalation (DPIs), particularly for tuberculosis and lung cancer.
  • Designing, development, and evaluation of polymeric particulate drug delivery systems (microparticles, Nanoparticles, Porous Nanoparticle Aggregates (PNAP)) for Pulmonary, Nasal and transdermal administration.  
  • Development of antigen and adjuvant loaded nano-carrier systems for immunization. 
  • In vitro and in vivo evaluation of novel drug delivery platforms, preclinical drug evaluation in cell lines animal models.


Share :